TY - JOUR
T1 - Frailty, mortality, and health care utilization after liver transplantation
T2 - From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
AU - from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study
AU - Lai, Jennifer C.
AU - Shui, Amy M.
AU - Duarte-Rojo, Andres
AU - Ganger, Daniel R.
AU - Rahimi, Robert S.
AU - Huang, Chiung Yu
AU - Yao, Frederick
AU - Kappus, Matthew
AU - Boyarsky, Brian
AU - McAdams-Demarco, Mara
AU - Volk, Michael L.
AU - Dunn, Michael A.
AU - Ladner, Daniela P.
AU - Segev, Dorry L.
AU - Verna, Elizabeth C.
AU - Feng, Sandy
N1 - Funding Information:
This study was funded by NIH K23AG048337 (to J.C.L.), NIH R01AG059183 (to J.C.L.), NIH F32DK124941 (to B.B.), NIH P30DK026743 (to J.C.L., A.M.S., C.‐Y.H.), and NIH K24DK101828 (to D.L.S.). These funding agencies played no role in the analysis of the data or the preparation of this manuscript
Publisher Copyright:
© 2021 American Association for the Study of Liver Diseases.
PY - 2022/6
Y1 - 2022/6
N2 - Background and Aims: Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown. Approach and Results: Adult LT recipients from 8 US centers (2012–2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). “Frail” was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define “prolonged” post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08–2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39–3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47–2.73), ICU stay (OR, 1.56; 95% CI, 1.12–2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25–2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58–3.97). Conclusions: Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.
AB - Background and Aims: Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown. Approach and Results: Adult LT recipients from 8 US centers (2012–2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). “Frail” was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define “prolonged” post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08–2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39–3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47–2.73), ICU stay (OR, 1.56; 95% CI, 1.12–2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25–2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58–3.97). Conclusions: Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.
UR - http://www.scopus.com/inward/record.url?scp=85122101479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122101479&partnerID=8YFLogxK
U2 - 10.1002/hep.32268
DO - 10.1002/hep.32268
M3 - Article
C2 - 34862808
AN - SCOPUS:85122101479
SN - 0270-9139
VL - 75
SP - 1471
EP - 1479
JO - Hepatology
JF - Hepatology
IS - 6
ER -